No one has seen these results before with any regimen over any period of time. They can't get any better. |
Vertex achieved all of its clinical, research and financial objectives in 2005. In particular, we increased our financial strength as we advanced potentially transformational compounds targeting hepatitis C virus (HCV), rheumatoid arthritis and cystic fibrosis. Our performance last year has positioned us to build momentum in 2006. |
Vertex's cystic fibrosis research program has yielded two innovative approaches for the treatment of this disease. |